JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409841200 on December 9, 2004

J. Biol. Chem., Vol. 280, Issue 8, 7080-7087, February 25, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/8/7080    most recent
M409841200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, E. M.
Right arrow Articles by Iozzo, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, E. M.
Right arrow Articles by Iozzo, R. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan*

Eva M. Gonzalez{ddagger}§, Charles C. Reed{ddagger}§, Gregory Bix{ddagger}, Jian Fu{ddagger}, Yue Zhang¶, Bagavathi Gopalakrishnan¶, Daniel S. Greenspan¶, and Renato V. Iozzo{ddagger}||**

From the {ddagger}Department of Pathology, Anatomy and Cell Biology and the ||Cellular Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and the Department of Pathology and Laboratory Medicine, and Program in Cellular and Molecular Biology, University of Wisconsin Medical School, Madison, Wisconsin 53706

Endorepellin, the C-terminal domain of the heparan sulfate proteoglycan perlecan, possesses angiostatic activity. The terminal laminin-like globular (LG3) domain of endorepellin appears to possess most of the biological activity on endothelial cells. LG3 protein has been detected in the urine of patients with end-stage renal disease and in the amniotic fluid of pregnant women with premature rupture of fetal membranes. These findings suggest that proteolytic processing of endorepellin and the generation of LG3 might have biological significance. In this study, we have identified specific enzymes of the bone morphogenetic protein-1 (BMP-1)/Tolloid family of metalloproteases that cleave LG3 from recombinant endorepellin at the physiologically relevant site and that cleave LG3 from endogenous perlecan in cultured mouse and human cells. The BMP-1/Tolloid family of metalloproteases is thereby implicated in the processing of a major basement membrane proteoglycan and in the liberation of an anti-angiogenic factor. Using molecular modeling, site-directed mutagenesis and angiogenic assays, we further demonstrate that LG3 activity requires specific amino acids involved in Ca2+ coordination.


Received for publication, August 26, 2004 , and in revised form, December 9, 2004.

* This work was supported by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 and Department of the Army grant DAMD17-00-1-0425 (to R. V. I.) and by National Institutes of Health Grants RO1 GM63471 and RO1 AR47746 (to D. S. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

** To whom correspondence should be addressed: Dept. of Pathology, Anatomy and Cell Biology, Rm. 249 JAH, Thomas Jefferson University, 1020 Locust St., Philadelphia, PA 19107. E-mail: iozzo{at}mail.jci.tju.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Smadja, I. Bieche, J.-S. Silvestre, S. Germain, A. Cornet, I. Laurendeau, J.-P. Duong-Van-Huyen, J. Emmerich, M. Vidaud, M. Aiach, et al.
Bone Morphogenetic Proteins 2 and 4 Are Selectively Expressed by Late Outgrowth Endothelial Progenitor Cells and Promote Neoangiogenesis
Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2137 - 2143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert
Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis
J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. J. Zoeller, A. McQuillan, J. Whitelock, S.-Y. Ho, and R. V. Iozzo
A central function for perlecan in skeletal muscle and cardiovascular development
J. Cell Biol., April 21, 2008; 181(2): 381 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Woodall, A. Nystrom, R. A. Iozzo, J. A. Eble, S. Niland, T. Krieg, B. Eckes, A. Pozzi, and R. V. Iozzo
Integrin {alpha}2 1 Is the Required Receptor for Endorepellin Angiostatic Activity
J. Biol. Chem., January 25, 2008; 283(4): 2335 - 2343.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. C Farach-Carson and D. D Carson
Perlecan a multifunctional extracellular proteoglycan scaffold
Glycobiology, September 1, 2007; 17(9): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Ge, C. A. Fernandez, M. A. Moses, and D. S. Greenspan
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor
PNAS, June 12, 2007; 104(24): 10010 - 10015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Bix, R. A. Iozzo, B. Woodall, M. Burrows, A. McQuillan, S. Campbell, G. B. Fields, and R. V. Iozzo
Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the {alpha}2{beta}1-integrin receptor
Blood, May 1, 2007; 109(9): 3745 - 3748.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. Bix, R. Castello, M. Burrows, J. J. Zoeller, M. Weech, R. A. Iozzo, C. Cardi, M. L. Thakur, C. A. Barker, K. Camphausen, et al.
Endorepellin In Vivo: Targeting the Tumor Vasculature and Retarding Cancer Growth and Metabolism.
J Natl Cancer Inst, November 15, 2006; 98(22): 1634 - 1646.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Whitman and L. Raftery
TGF{beta} signaling at the summit
Development, October 1, 2005; 132(19): 4205 - 4210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Moali, B. Font, F. Ruggiero, D. Eichenberger, P. Rousselle, V. Francois, A. Oldberg, L. Bruckner-Tuderman, and D. J. S. Hulmes
Substrate-specific Modulation of a Multisubstrate Proteinase: C-TERMINAL PROCESSING OF FIBRILLAR PROCOLLAGENS IS THE ONLY BMP-1-DEPENDENT ACTIVITY TO BE ENHANCED BY PCPE-1
J. Biol. Chem., June 24, 2005; 280(25): 24188 - 24194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.